Cooper Mr
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 4
- CAR-T cell therapy research 2
- Cancer Risks and Factors 2
-
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Spurr Cl (9 shared papers)Frederick Richards (8 shared papers)Glicksman As (1 shared paper)N I Nissen (1 shared paper)Leon Stutzman (1 shared paper)A. Gottlieb (1 shared paper)Muss Hb (3 shared papers)Capizzi Rl (3 shared papers)
- Journals
- Blood (1 paper)PubMed (27 papers)
- Partner nations
- United States
In The Last Decade
Cooper Mr
27 papers receiving 467 citations
Peers
Comparison fields: 5 of 68
- Hematology 229
- Genetics 74
- Public Health, Environmental and Occupational Health 163
- Oncology 154
- Pathology and Forensic Medicine 95
Countries citing papers authored by Cooper Mr
This map shows the geographic impact of Cooper Mr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cooper Mr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cooper Mr more than expected).
Fields of papers citing papers by Cooper Mr
This network shows the impact of papers produced by Cooper Mr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cooper Mr. The network helps show where Cooper Mr may publish in the future.
Co-authors
The 25 scholars most cited alongside Cooper Mr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 169 | |
| 2 | Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study. | 1982 | 137 |
| 3 | Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial. | 1986 | 36 |
| 4 | Pharmacokinetics of vincristine infusion. | 1982 | 35 |
| 5 | A review of the clinical studies of alpha-interferon in the management of multiple myeloma. | 1991 | 18 |
| 6 | Stimulation of oxidative metabolism in polymorphonuclear leukocytes by catecholamines. | 1972 | 16 |
| 7 | Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules. | 1986 | 15 |
| 8 | Respiratory syncytial virus infection in children in West Bengal. | 1971 | 13 |
| 9 | Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study. | 1978 | 10 |
| 10 | Interferons in the management of multiple myeloma. | 1988 | 10 |
| 11 | Postoperative complications in patients receiving suramin therapy. | 1994 | 9 |
| 12 | Comparison of the usefulness of bone marrow sections and smears in diagnosis of multiple myeloma. | 1987 | 9 |
| 13 | Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix. | 1977 | 8 |
| 14 | Adriamycin and CCNU in the treatment of advanced breast cancer. | 1976 | 7 |
| 15 | Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies. | 1985 | 6 |
| 16 | Phase I study of continuous infusion 6-thioguanine in patients with acute leukemia. | 1995 | 6 |
| 17 | Chemotherapy versus observation in high-risk node-negative breast cancer patients. | 1992 | 5 |
| 18 | Acute lower respiratory tract infections in Calcutta children: An etiologic study. | 1966 | 5 |
| 19 | Chemoinfusion of the hepatic artery for metastases to the liver. | 1989 | 4 |
| 20 | Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience. | 1995 | 3 |
About Cooper Mr
Cooper Mr is a scholar working on Oncology, Hematology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 531 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Hematological disorders and diagnostics (3 papers), Breast Cancer Treatment Studies (2 papers), CAR-T cell therapy research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Hematology (229 citations), Genetics (74 citations), Public Health, Environmental and Occupational Health (163 citations), Oncology (154 citations) and Pathology and Forensic Medicine (95 citations). Cooper Mr has collaborated with scholars based in United States. Frequent co-authors include Spurr Cl, Frederick Richards, Glicksman As, N I Nissen, Leon Stutzman, A. Gottlieb, Muss Hb, Capizzi Rl, Matthew Poole and Prichard Rw. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.